MedPath

The Strontium Chloride Associated With Photobiomodulation in the Control of Post-bleaching Sensitivity

Not Applicable
Completed
Conditions
Dentin Sensitivity
Interventions
Other: PLACEBO (Negative Control)
Other: ESTRÔNCIO
Other: FBM
Other: FBM+ESTRÔNCIO
Registration Number
NCT04356911
Lead Sponsor
Universidade Federal do Para
Brief Summary

This study investigated the effects of the association of strontium chloride with photobiomodulation on the dental bleaching process, testing the hypothesis that they may control dental sensitivity post-bleaching teeth.

Detailed Description

The objective of this double-blind, randomized, controlled clinical study was to evaluate the effect of 10% strontium chloride associated with photobiomodulation (FBM) on teeth exposed to 35% hydrogen peroxide during 3 weeks of whitening treatment. Methods: 50 volunteers were evaluated by the split mouth model, where the hemiarchy patients were randomized and subsequently allocated to one of the experimental groups: PLACEBO (negative control) - group with no desensitizing treatment, only bleached; FBM (positive control) - group treated with placebo gel and application of the LLLT (Low Level Laser Therapy); ESTRÔNCIO (positive control) - group treated with 10% strontium chloride and simulation of LLLT application (without light emission); and FBM + ESTRÔNCIO - group treated with LLLT + 10% strontium chloride.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • good oral hygiene
  • absence of active caries lesions
  • never having undergone previous whitening therapy
  • not present dental hypersensitivity
  • don't be a smoker
  • not be pregnant
  • present at least 28 teeth in the oral cavity.
Exclusion Criteria
  • volunteers who were under orthodontic treatment,
  • presence of periodontal disease
  • dental cracks or fractures
  • restorations and prostheses on anterior teeth
  • extensive molar restorations
  • gastroesophageal disorders
  • severe internal dental darkening
  • presence of dentinal exposure in anterior and / or posterior teeth.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
PLACEBO (Negative Control)PLACEBO (Negative Control)The dental elements of this group had no desensitizing treatment. After whitening therapy, a water-soluble placebo gel (KY®, Johnson \& Johnson, SP, Brazil) was applied to dental oral surfaces, then the laser tip was positioned at two points, apical and cervical, without emitting light (placebo), simulating the application of Low Level Laser Therapy (LLLT).
ESTRÔNCIOESTRÔNCIOAfter whitening in-office bleaching, the group was treated with desensitization to 10% strontium chloride. Subsequently, a laser tip was positioned at two points (apical and cervical), without emitting light (placebo).
FBMFBMThe group received the application of a placebo gel associated with LLLT after office bleaching.
FBM+ESTRÔNCIOFBM+ESTRÔNCIOAfter whitening in the office, the group received a 10% strontium chloride desensitizer associated with low level light therapy.
Primary Outcome Measures
NameTimeMethod
Efficacy of desensitizer treatment in the control of tooth post-bleaching sensitivity (P21)21 days

Self-reported pain intensity was assessed daily, during 21 days, through self-perception questionnaire, answered by the patients from the first tooth bleaching session until one week after the last session. The evaluation was performed by each patient, according to a modified visual analog scale, as follows: 0- no pain, 1 mild pain, 2 - moderate pain and 3 -severe pain.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Para's Federal University

🇧🇷

Belém, Pará, Brazil

© Copyright 2025. All Rights Reserved by MedPath